Garo H. Armen, Executive CHAIR & PRINCIPAL Officer at Protagenic Therapeutics, Inc.\new (PTIX), bought 20,000 shares at $0.65 ($13K) on 2026-08-21, disclosed to the SEC on 2026-08-24.
Executive Chair Garo H. Armen purchased 20,000 shares at $0.65 on August 21, 2026, signaling confidence in the stock's recovery potential following a steep year-long decline. This move comes as the stock trades near its 52-week low, presenting a potential value entry point for traders.
The stock is currently trading at $0.73, representing a 3.99% distance from its 52-week low of $0.702 and a massive 82.78% decline over the past year. The price has been relatively flat over the last 30 days, consolidating near the bottom of its annual range.
Insider purchase on August 21, 2026; stock trading within 4% of 52-week low at $0.73.
The stock is down 82.78% over the past year, indicating significant fundamental or market challenges that could persist despite the recent insider buying.
Nothing distinguishes this filing.
| Filing → |
| PTIX | BUY | 2026-08-12 | $710 | — | Filing → |
| PTIX | BUY | 2026-08-10 | $151 | — | Filing → |
| PTIX | BUY | 2026-08-06 | $1K | — | Filing → |